Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Asset Writedowns and Impairment (2018 - 2025)

MedWellAI (MWAI) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $648715.0 as the latest value for Q2 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $648715.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $752125.0, a N/A change, with the full-year FY2025 number at $752125.0, changed N/A from a year prior.
  • Asset Writedowns and Impairment was $648715.0 for Q2 2025 at MedWellAI, up from $103410.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $648715.0 in Q2 2025 to a low of $103410.0 in Q3 2024.